Abstract
Osteoclasts are highly specialized multinucleated cells derived from the monocyte/macrophage hematopoietic lineage that are uniquely capable of adhering to bone matrix and resorbing bone. The tartrate-resistant acid phosphatase (TRAP) assay is the most common method to detect osteoclasts population in vitro. Here we described a general protocol of inducing osteoclast differentiation from the murine macrophage cell line, RAW264.7, and identification of osteoclasts with the classical TRAP assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldberg AF, Barka T (1962) Acid phosphatase activity in human blood cells. Nature 195:297
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342
Chambers TJ (2000) Regulation of the differentiation and function of osteoclasts. J Pathol 192:4–13
Marino S, Logan JG, Mellis D, Capulli M (2014) Generation and culture of osteoclasts. Bonekey Rep 3:570
Takahashi N, Udagawa N, Kobayashi Y, Suda T (2007) Generation of osteoclasts in vitro, and assay of osteoclast activity. Methods Mol Med 135:285–301
Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A et al (2001) Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370–377
McSheehy PM, Chambers TJ (1986) Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824–828
Arnett TR, Dempster DW (1987) A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins. Endocrinology 120:602–608
Boyde A, Ali NN, Jones SJ (1984) Resorption of dentine by isolated osteoclasts in vitro. Br Dent J 156:216–220
Murrills RJ, Shane E, Lindsay R, Dempster DW (1989) Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin. J Bone Miner Res 4:259–268
Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM et al (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600–2602
Hemingway F, Cheng X, Knowles HJ, Estrada FM, Gordon S, Athanasou NA (2011) In vitro generation of mature human osteoclasts. Calcif Tissue Int 89:389–395
Indo Y, Takeshita S, Ishii KA, Hoshii T, Aburatani H, Hirao A et al (2013) Metabolic regulation of osteoclast differentiation and function. J Bone Miner Res 28:2392–2399
Quinn JM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424–4427
Tevlin R, McArdle A, Chan CK, Pluvinage J, Walmsley GG, Wearda T et al (2014) Osteoclast derivation from mouse bone marrow. J Vis Exp:e52056
Xing L, Boyce BF (2014) RANKL-based osteoclastogenic assays from murine bone marrow cells. Methods Mol Biol 1130:307–313
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597–3602
Yasuda H (2013) RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases. World J Orthop 4:207–217
Yoshida H, Hayashi SI, Kunisada T, Ogawa M, Nishikawa S, Okamura H et al (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–444
Park JH, Lee NK, Lee SY (2017) Current understanding of rank signaling in osteoclast differentiation and maturation. Mol Cells 40:706–713
Takahashi N, Udagawa N, Suda T (1999) A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Bioph Res Commun 256:449–455
Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108–1118
Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275–285
Hsu HL, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E et al (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540–3545
Coxon FP, Rogers MJ, Crockett JC (2012) Isolation and purification of rabbit osteoclasts. Methods Mol Biol 816:145–158
Itzstein C, van’t Hof RJ (2012) Osteoclast formation in mouse co-cultures. Methods Mol Biol 816:177–186
Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA et al (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81–86
Matsubara T, Myoui A, Ikeda F, Hata K, Yoshikawa H, Nishimura R et al (2006) Critical role of cortactin in actin ring formation and osteoclastic bone resorption. J Bone Miner Metab 24:368–372
Matsubara T, Kinbara M, Maeda T, Yoshizawa M, Kokabu S, Takano YT (2017) Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin. Biochem Biophys Res Commun 489:472–476
Nakamura I, Takahashi N, Sasaki T, Jimi E, Kurokawa T, Suda T (1996) Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res 11:1873–1879
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yang, J., Bi, X., Li, M. (2019). Osteoclast Differentiation Assay. In: Su, G. (eds) Pancreatic Cancer. Methods in Molecular Biology, vol 1882. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8879-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8879-2_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8878-5
Online ISBN: 978-1-4939-8879-2
eBook Packages: Springer Protocols